Ketoprofen Extended-Release Capsules and Methscopolamine Bromide
Determining the interaction of Ketoprofen Extended-Release Capsules and Methscopolamine Bromide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ketoprofen
Brand name: Oruvail, Orudis, Actron, Orudis KT
Synonyms: Ketoprofen
Generic Name: methscopolamine
Brand name: Pamine, Pamine Forte
Synonyms: Methscopolamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ketoprofen Extended-Release Capsules-Methsuximide
- Ketoprofen Extended-Release Capsules-Methyclothiazide
- Ketoprofen Extended-Release Capsules-Methyl Aminolevulinate
- Ketoprofen Extended-Release Capsules-Methyl aminolevulinate topical
- Ketoprofen Extended-Release Capsules-Methyl aminolevulinate Topical application
- Ketoprofen Extended-Release Capsules-Methyl B-12 vitamin B12
- Methscopolamine Bromide-Ketorolac
- Methscopolamine Bromide-Ketorolac (Systemic)
- Methscopolamine Bromide-Ketorolac Eye Drops (Multi-Dose Containers)
- Methscopolamine Bromide-Ketorolac Eye Drops (Single-Dose Containers)
- Methscopolamine Bromide-Ketorolac Injection
- Methscopolamine Bromide-Ketorolac nasal